Premium
MultiCell Technologies Inc (CE) (MCET)
USOTC
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Aprill 12, 2021 -- InvestorsHub NewsWire -- via Stockcharts.com/PAOG PAOG News Out On CBD RX Update PAOG Advances CBD Pharmaceutical Developments Backed By US...
MultiCell Immunotherapeutics And Oxis Biotech Sign Antibody-Drug Conjugate R&D, Product License And Commercialization Agreement PR Newswire WOONSOCKET, R.I., March 12, 2015 WOONSOCKET, R.I...
MultiCell Technologies Files Novel Antibody-Drug Conjugate Patent Application PR Newswire WOONSOCKET, R.I., Dec. 10, 2014 WOONSOCKET, R.I., Dec. 10, 2014 /PRNewswire/ -- MultiCell Technologies...
MultiCell Technologies Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer PR Newswire WOONSOCKET, R.I., Aug. 25, 2014 WOONSOCKET, R.I., Aug. 25, 2014 /PRNewswire/...
MultiCell Technologies Files U.S. and International Patent Applications for the Treatment of Liver Cancer PR Newswire WOONSOCKET, R.I., March 20, 2014 WOONSOCKET, R.I., March 20, 2014...
MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics PR Newswire WOONSOCKET, R.I., Jan. 15, 2014 WOONSOCKET, R.I., Jan. 15, 2014 /PRNewswire/ -- MultiCell...
MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of MCT-485, a Noncoding miRNA for Cancer Treatment PR Newswire WOONSOCKET, R.I., Nov. 13, 2013 WOONSOCKET, R.I., Nov...
MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer PR Newswire WOONSOCKET, R.I., Oct. 2, 2013 WOONSOCKET, R.I., Oct. 2, 2013 /PRNewswire/ -- MultiCell...
MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer PR Newswire WOONSOCKET, R.I., Aug. 6, 2013 WOONSOCKET, R.I., Aug. 6...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 400 | 1.0E-6 | CS |
| 4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 1041872 | 1.0E-6 | CS |
| 12 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 661158 | 1.0E-6 | CS |
| 26 | 0 | 0 | 1.0E-6 | 0.0002 | 1.0E-6 | 570748 | 1.0E-6 | CS |
| 52 | 0 | 0 | 1.0E-6 | 0.0005 | 1.0E-6 | 676678 | 1.284E-5 | CS |
| 156 | 0 | 0 | 1.0E-6 | 0.001 | 1.0E-6 | 730225 | 2.791E-5 | CS |
| 260 | 0 | 0 | 1.0E-6 | 0.0083 | 1.0E-6 | 34456725 | 0.00233213 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
